Ohh M - Search Results

1

Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma.

Gervais ML, Henry PC, Saravanan A, Burry TN, Gallie BL, Jewett MA, Hill RP, Evans AJ, Ohh M. Gervais ML, et al. Among authors: ohh m. Lab Invest. 2007 Dec;87(12):1252-64. doi: 10.1038/labinvest.3700684. Epub 2007 Oct 1. Lab Invest. 2007. PMID: 17906660 Free article.

2

Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex.

Maynard MA, Qi H, Chung J, Lee EH, Kondo Y, Hara S, Conaway RC, Conaway JW, Ohh M. Maynard MA, et al. Among authors: ohh m. J Biol Chem. 2003 Mar 28;278(13):11032-40. doi: 10.1074/jbc.M208681200. Epub 2003 Jan 21. J Biol Chem. 2003. PMID: 12538644 Free article.

3

The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway.

Qi H, Ohh M. Qi H, et al. Among authors: ohh m. Cancer Res. 2003 Nov 1;63(21):7076-80. Cancer Res. 2003. PMID: 14612498

4

Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.

Maynard MA, Ohh M. Maynard MA, et al. Among authors: ohh m. Am J Nephrol. 2004 Jan-Feb;24(1):1-13. doi: 10.1159/000075346. Epub 2003 Dec 3. Am J Nephrol. 2004. PMID: 14654728 Review.

5

Molecular cloning and characterization of the von Hippel-Lindau-like protein.

Qi H, Gervais ML, Li W, DeCaprio JA, Challis JR, Ohh M. Qi H, et al. Among authors: ohh m. Mol Cancer Res. 2004 Jan;2(1):43-52. Mol Cancer Res. 2004. PMID: 14757845

6

pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development.

Stickle NH, Chung J, Klco JM, Hill RP, Kaelin WG Jr, Ohh M. Stickle NH, et al. Among authors: ohh m. Mol Cell Biol. 2004 Apr;24(8):3251-61. doi: 10.1128/MCB.24.8.3251-3261.2004. Mol Cell Biol. 2004. PMID: 15060148 Free PMC article.

7

The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.

Sufan RI, Jewett MA, Ohh M. Sufan RI, et al. Among authors: ohh m. Am J Physiol Renal Physiol. 2004 Jul;287(1):F1-6. doi: 10.1152/ajprenal.00424.2003. Am J Physiol Renal Physiol. 2004. PMID: 15180922 Free article. Review.

8

Tumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain.

Lolkema MP, Gervais ML, Snijckers CM, Hill RP, Giles RH, Voest EE, Ohh M. Lolkema MP, et al. Among authors: ohh m. J Biol Chem. 2005 Jun 10;280(23):22205-11. doi: 10.1074/jbc.M503220200. Epub 2005 Apr 11. J Biol Chem. 2005. PMID: 15824109 Free article.

9

Expression of p53 in renal carcinoma cells is independent of pVHL.

Stickle NH, Cheng LS, Watson IR, Alon N, Malkin D, Irwin MS, Ohh M. Stickle NH, et al. Among authors: ohh m. Mutat Res. 2005 Oct 15;578(1-2):23-32. doi: 10.1016/j.mrfmmm.2005.02.016. Epub 2005 Jul 5. Mutat Res. 2005. PMID: 15998523

10

Molecular targets from VHL studies into the oxygen-sensing pathway.

Maynard MA, Ohh M. Maynard MA, et al. Among authors: ohh m. Curr Cancer Drug Targets. 2005 Aug;5(5):345-56. doi: 10.2174/1568009054629672. Curr Cancer Drug Targets. 2005. PMID: 16101382 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters